Skip to content
Screener

OrthoPediatrics KIDS Q1 2026 earnings

Reported April 30, 2026 · After market close

Revenue$59.4MBeat by $1.1M
EPS-$0.42Miss by $0.04
Revenue estimate$58.3M
EPS estimate-$0.38

Next report

Oct 27, 2026 (in a month)
Revenue estimate$68.5M
EPS estimate-$0.25

Financials

Q1 2026

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$401.17M-32.9%
Enterprise value$392.34M-30.5%
P/S1.6×-1.2×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0×0.0×
Current ratio5.2×-1.0×

Segments

By product

See full
Trauma and deformity$43.0M+13.7%
Scoliosis$15.4M+13.0%
Sports medicine/other$875.0K-0.6%

FAQ

When did OrthoPediatrics report Q1 2026 earnings?
OrthoPediatrics (KIDS) reported Q1 2026 earnings on April 30, 2026 after market close.
What were OrthoPediatrics's Q1 2026 revenue and EPS?
OrthoPediatrics reported revenue of $59.4M and eps of $-0.42 for Q1 2026.
Did OrthoPediatrics beat estimates in Q1 2026?
Revenue beat the consensus estimate of $58.3M by $1.1M. EPS missed the consensus estimate of $-0.38 by $0.04.
How did OrthoPediatrics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.3% from $52.4M a year earlier and eps declined 7.7% from $-0.39.
Where can I find OrthoPediatrics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001425450-26-000032) and the 10-Q periodic report (0001425450-26-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.